Abstract
Trichotillomania, or hair-pulling disorder, is a functionally impairing, often overlooked disorder, with no US FDA-approved medications for its treatment. Several pharmacological studies, however, have offered promise for those with trichotillomania, but the ability of clinical trials to detect beneficial effects of active treatment in trichotillomania has been hampered by a lack of understanding of the possible subtypes of trichotillomania and the unusually high placebo response rate.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
